HITLAB Expands Breakthrough Alliance Board with the addition of Dr. Glennis Mehra, Director Biolabs at NYU Langone

Clinical Trial Adherence Intelligence

Curio Digital Therapeutics: Pivotal Trial for Postpartum Depression Digital Therapeutic Meets Efficacy Endpoints

HITLAB Welcomes Laurent van Lerberghe as New Board Member of Breakthrough Alliance and Chairman of Board for Europe

How Start-up BirthVue Is Helping Moms During Labor and Delivery

Clinical Trials Designed for the Patient: How Remote Technologies Improve Engagement

Applications Open for HITLAB Fall 2023 Breakthrough Alliance Challenge

HITLAB, Columbia University and Babbly announce the results of an external validation study

HelixVM™ teams up with HITLAB to enhance its medical marketplace, fortifying triage clearinghouse and fast-tracking patient care